The preference for radial artery access for interventional operations is steadily rising around the world. The numerous advantages of this approach in transarterial chemoembolization, in cancer treatment, are fuelling the surge in the preference for transradial access devices. Moreover, the suitability of the procedure for a wide range of patients, such as morbidly obese patients, those suffering from severe peripheral vascular diseases, elderly (especially women), and those on oral anticoagulation medicines, and thus, at an extremely high risk of vascular access site bleeding, makes these devices highly sought-after.  

Moreover, the lower cost and favorable clinical outcomes of the transradial access procedure, as compared to the transfemoral approach, is expected to reduce healthcare expenses, especially in the emerging economies. Therefore, the global transradial access devices market is expected to witness an increase in its valuation from $14.9 billion in 2017 to $24.1 billion by 2023, at a CAGR of 8.4% during the forecast period (2018–2023). Transradial access simply means to snake a catheter or tube into the body via the radial artery, which runs through the forearm. 

Browse detailed report - Transradial Access Devices Market Analysis and Demand Forecast Report

Geographically, Europe witnessed the largest sale of transradial access devices in 2017. This was mainly due to the wide-scale acceptance and utilization of transradial intervention (TRI), as the default procedure for percutaneous coronary interventions (PCI), in Europe. In addition to this, the setting up of outpatient clinics, providing same-day discharge from cath labs, performing TRI, further boosted the demand for transradial access devices here. On the basis of country-wise analysis, the U.S., Canada, and Japan are expected to record the highest demand for such instruments, amongst the developed nations, during the forecast period. 

Therefore, it can be concluded that the demand for transradial access devices is set to skyrocket in the coming years, owing to the numerous advantages offered by them over snaking a catheter or tubing through the femoral vein in the thigh.